AIDS Healthcare Foundation (AHF) reported on Wednesday that the US will have 3m vaccine doses per day available by April in the fight against the COVID-19 variants.
In conjunction, the company's Ryan White HIV Clinics will offer its sites to administer the COVID-19 vaccines.
On Tuesday, AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer have reportedly testified at the US House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations. Each company presented the scaled-up production numbers for the vaccines that have been approved by the US Food and Drug Administration (FDA).
AHF is the largest global AIDS organization and currently provides medical care and/or services to over 1.5m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region as well as Eastern Europe.
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Precision Epigenomics partners with TruDiagnostic
Illumina's GRAIL divestment plan receives EC approval
Soligenix receives orphan drug designation from FDA for active ingredient in SuVax
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Ondine Biomedical's Steriwave approved for use by HCA UK
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial
Syros receives Fast Track Designation from FDA for tamibarotene in AML